Effectiveness of Methylene Blue Guidance in Total Excision of Pilonidal Sinus.

Methylene bleu use in pilonidal sinus surgery is not an effective guidance as expected.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pilonidal Sinus Cysts Neoplasms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bezmialem Vakif University, Faculty of Medicine, Department of Surgery

Istanbul, 34093, Turkey (Türkiye)

About this study

To study the potential benefits of intraoperative methylene blue use in pilonidal sinus surgery in detecting the borders of the disease, the histopathologic correlation between the specimen dyed by methylene blue and also the cavity excision specimen not dyed by methylene blue was investigated. The branches that distinctly exceeded the planned dyed excision borders will tried to be detected histopathologically, if any.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pilonidal sinus disease of the intergluteal region
Primary disease without history of drainage
Ages between 18 and 65, both gender

Exclusion criteria

Recurrent pilonidal sinus disease
Acute infection with abscess formation and/or purulent copious drainage
Denial to sign informed consent

Treatment and study plan

Pilonidal sinus excision

Procedure

The dyed portion of the excised pilonidal sinus and non-dyed cavity excision specimen will be studied histopathologically to detect any remnant of pilonidal sinus.

Primary outcomes

Histopathologic detection of any evidence of pilonidal sinus disease in the cavity excision material not dyed by methylene blue

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Bezmialem Vakif University

Other

Registry information

Official study title

Does Intraoperative Methylene Blue Guidance in Pilonidal Sinus Surgery Really Effective in Total Excision of the Nest ?

Acronym: BAVUGC-2

Important dates

Study start: 2012
Primary completion: 2012
Study completion: 2012
First posted: Jan 20, 2012
Registry last updated: Jul 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed